[{"address1": "Rue Edouard Belin 12", "city": "Mont-Saint-Guibert", "zip": "1435", "country": "Belgium", "phone": "32 10 22 23 55", "website": "https://www.nyxoah.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.", "fullTimeEmployees": 146, "maxAge": 86400, "priceHint": 2, "previousClose": 9.17, "open": 8.83, "dayLow": 8.42, "dayHigh": 8.83, "regularMarketPreviousClose": 9.17, "regularMarketOpen": 8.83, "regularMarketDayLow": 8.42, "regularMarketDayHigh": 8.83, "beta": 0.528, "forwardPE": -4.9766083, "volume": 7842, "regularMarketVolume": 7842, "averageVolume": 41972, "averageVolume10days": 31830, "averageDailyVolume10Day": 31830, "bid": 5.0, "bidSize": 20000, "marketCap": 303512576, "fiftyTwoWeekLow": 4.0, "fiftyTwoWeekHigh": 20.0, "priceToSalesTrailing12Months": 59.18732, "fiftyDayAverage": 9.3584, "twoHundredDayAverage": 8.71381, "currency": "USD", "enterpriseValue": 212534224, "floatShares": 11005814, "sharesOutstanding": 34360400, "sharesShort": 59779, "sharesShortPriorMonth": 268182, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0021, "heldPercentInsiders": 0.42575002, "heldPercentInstitutions": 0.27392998, "shortRatio": 1.87, "shortPercentOfFloat": 0.0047, "impliedSharesOutstanding": 35665400, "bookValue": 3.04, "priceToBook": 2.7993422, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -43207000, "trailingEps": -1.61, "forwardEps": -1.71, "enterpriseToRevenue": 41.446, "enterpriseToEbitda": -4.696, "52WeekChange": 0.046740413, "SandP52WeekChange": 0.26238096, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NYXH", "underlyingSymbol": "NYXH", "shortName": "Nyxoah SA", "longName": "Nyxoah S.A.", "firstTradeDateEpochUtc": 1619616600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "067cdc20-d2e6-3884-af4a-437fe8703370", "messageBoardId": "finmb_264235912", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.51, "targetHighPrice": 26.9, "targetLowPrice": 14.94, "targetMeanPrice": 19.33, "targetMedianPrice": 17.93, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 44302000, "totalCashPerShare": 1.545, "ebitda": -45255000, "totalDebt": 12747000, "quickRatio": 3.6, "currentRatio": 3.941, "totalRevenue": 5128000, "debtToEquity": 14.619, "revenuePerShare": 0.179, "returnOnAssets": -0.21745001, "returnOnEquity": -0.40717998, "freeCashflow": -39521876, "operatingCashflow": -46389000, "revenueGrowth": 1.769, "grossMargins": 0.62246, "operatingMargins": -10.00246, "financialCurrency": "EUR", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]